ARTICLE | Company News
Newco Vytacera in-licenses cyanide poisoning treatment
February 10, 2012 1:19 AM UTC
The University of Minnesota granted California-based newco Vytacera Pharma Inc. exclusive, worldwide rights to develop and commercialize cyanide poisoning treatment Sulfanegen. The prodrug of 3-mercap...